Synlett
DOI: 10.1055/a-2316-5200
letter
Special Issue to Celebrate the 75th Birthday of Prof. B. C. Ranu

One-Pot Expeditious Synthesis of Pyrazoloindolones via Base-Promoted Electrocyclization, C–N Coupling and Intramolecular Oxidative Cyclization

Harshita Singh Korawat
,
Manoj Kumar Saini
,
Karmdeo Prajapati
,
,
Ashok Kumar Basak
Research grants from Council of Scientific and Industrial Research (Grant No. 02(0346)/19/EMR-II) and Science and Engineering Research Board, New Delhi (Grant No. CRG/2023/000021 and CRG/2023/000121), and the Institute of Eminence, Banaras Hindu University (IoE-BHU, Seed Grant 6031) are gratefully acknowledged.


Abstract

Pyrazoloindolones are synthesized from N-tosylhydrazones in a one-pot multistep process which include base-promoted (i) electrocyclization reaction of N-tosylhydrazones derived from α,β-unsaturated aldehydes, (ii) aromatic nucleophilic substitution, and (iii) a domino cyclization–oxidation process under aerobic conditions.

Supporting Information



Publication History

Received: 28 March 2024

Accepted after revision: 29 April 2024

Accepted Manuscript online:
29 April 2024

Article published online:
14 May 2024

© 2024. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References and Notes

    • 1a Cherukupalli S, Karpoormath R, Chandrasekaran B, Hampannavar GA, Thapliyal N, Palakollu VN. Eur. J. Med. Chem. 2017; 126: 298
    • 1b Kaswan P, Pericherla K, Purohit D, Kumar A. Tetrahedron Lett. 2015; 56: 549
    • 1c Crossley EL, Issa F, Scarf AM, Kassiou M, Rendina LM. Chem. Commun. 2011; 47: 12179
    • 1d Al-Adiwish WM, Tahir MI. M, Siti-Noor-Adnalizawati A, Hashim SF, Ibrahim N, Yaacob WA. Eur. J. Med. Chem. 2013; 64: 464
    • 1e Selleri S, Bruni F, Costagli C, Costanzo A, Guerrini G, Ciciani G, Gratteri P, Besnard F, Costa B, Montali M, Martini C, Fohlin J, Siena GD, Aiello PM. J. Med. Chem. 2005; 48: 6756
    • 1f Kamal A, Tamboli JR, Nayak VL, Adil SF, Vishnuvardhan MV. P. S. Bioorg. Med. Chem. Lett. 2013; 23: 3208
    • 1g Ahmed OM, Mohamed MA, Ahmed RR, Ahmed SA. Eur. J. Med. Chem. 2009; 44: 3519
    • 1h Reynolds A, Hanani R, Hibbs D, Damont A, Da Pozzo E, Selleri S, Dolle F, Martini C, Kassiou M. Bioorg. Med. Chem. Lett. 2010; 20: 5799
    • 1i James ML, Fulton RR, Vercoullie J, Henderson DJ, Garreau L, Chalon S, Dolle F, Costa B, Guilloteau D, Kassiou M. J. Nucl. Med. 2008; 49: 814
    • 1j Senga K, Novinson T, Springer RH, Rao RP, O’Brien DE, Robins RK, Wilson HR. J. Med. Chem. 1975; 18: 312
    • 1k Xu Y, Brenning BG, Kultgen SG, Foulks JM, Clifford A, Lai S, Cha A, Merx S, McCullar MV, Kanner SB, Ho K.-K. ACS Med. Chem. Lett. 2015; 6: 63
    • 1l Tian Y, Du D, Rai D, Wang L, Liu H, Zhan P, De Clercq E, Pannecouque C, Liu X. Bioorg. Med. Chem. 2014; 22: 2052
    • 1m Dowling JE, Alimzhanov M, Bao L, Block MH, Chuaqui C, Cooke EL, Denz CR, Hird A, Huang S, Larsen NA. ACS Med. Chem. Lett. 2013; 4: 800
    • 2a De Mello H, Echevarria A, Bernardino AM, Canto-Cavalheiro M, Leon LL. J. Med. Chem. 2004; 47: 5427
    • 2b Sekikawa I, Nishie J, Tono-oka S, Tanaka Y, Kakimoto S. J. Heterocycl. Chem. 1973; 10: 931
    • 2c Tucker TJ, Sisko JT, Tynebor RM, Williams TM, Felock PJ, Flynn JA, Lai M.-T, Liang Y, McGaughey G, Liu M, Miller M, Moyer G, Munshi V, Perlow-Poehnelt R, Prasad S, Reid JC, Sanchez R, Torrent M, Vacca JP, Wan B.-L, Yan Y. J. Med. Chem. 2008; 51: 6503
    • 2d Ochiai H, Ishida A, Ohtani T, Kusumi K, Kishikawa K, Yamamoto S, Takeda H, Obata T, Makai H, Toda M. Bioorg. Med. Chem. 2004; 12: 4089
    • 2e Revesz L, Blum E, Di Padova FE, Buhl T, Feifel R, Gram H, Hiestand P, Manning U, Neumann U, Rucklin G. Bioorg. Med. Chem. Lett. 2006; 16: 262
    • 2f Bare TM, McLaren CD, Campbell JB, Firor JW, Resch JF, Walters CP, Salama AI, Meiners BA, Patel JB. J. Med. Chem. 1989; 32: 2561
    • 2g Hoehn H, Polacek I, Schulze E. J. Med. Chem. 1973; 16: 1340
    • 2h Chu I, Lynch BM. J. Med. Chem. 1975; 18: 161
    • 2i Shutske GM, Roehr JE. J. Heterocycl. Chem. 1997; 34: 789
    • 2j Henke BR, Aquino CJ, Birkemo LS, Croom DK. Jr, Ervin GN, Grizzle MK, Hirst GC, James MK, Johnson MF, Queen KL, Sherrill RG, Sugg EE, Suh EM, Szewczyk JW, Unwalla RJ, Yingling J, Willson TM. J. Med. Chem. 1997; 40: 2706
    • 2k Straub A, Benet-Buckholtz J, Frode R, Kern A, Kohlsdorfer C, Schmitt P, Schwarz T, Siefert H.-M, Stasch J.-P. Bioorg. Med. Chem. 2002; 10: 1711
  • 3 Kumar SV, Saraiah B, Parameshwarappa G, Ila H, Verma GK. J. Org. Chem. 2014; 79: 7961
    • 4a Kato K, Suzuki T, Ishihara H. JP 2002167305A 20020611, 2002
    • 4b Hu GQ, Hou LL, Yang Y, Yi L, Xie SQ, Wang GQ, Duan NN, Chao TY, Wen XY, Huang WL. Chin. Chem. Lett. 2011; 22: 804
    • 5a Mata G, Miles DH, Drew SL, Fournier J, Lawson KV, Mailyan AK, Sharif EU, Yan X, Beatty JW, Banuelos J, Chen J, Ginn E, Chen A, Gerrick KY, Pham AT, Wong K, Soni D, Dhanota P, Shaqfeh SG, Meleza C, Narasappa N, Singh H, Zhao X, Jin L, Schindler U, Walters MJ, Young SW, Walker NP, Leleti MR, Powers JP, Jeffrey JL. J. Med. Chem. 2022; 65: 1418
    • 5b Anand D, Yadav P, Patel O, Parmar N, Maurya R, Vishwakarma P, Raju K, Taneja I, Wahajuddin M, Kar S, Yadav P. J. Med. Chem. 2017; 60: 1041
  • 6 Li X, Yu Y, Tu Z. Molecules 2021; 26: 1202

    • For pyrrolo[1,2-a]indole-based natural products and bioactive molecules, see:
    • 7a Bass PD, Gubler DA, Judd TC, Williams RM. Chem. Rev. 2013; 113: 6816
    • 7b Pousset JL, Cave A, Chiaroni A, Riche C. J. Chem. Soc., Chem. Commun. 1977; 8: 261
    • 7c Fernandez LS, Sykes ML, Andrews KT, Avery VM. Int. J. Antimicrob. Agents 2010; 36 275
    • 7d Fernandez LS, Buchanan MS, Carroll AR, Feng YJ, Quinn RJ, Avery VM. Org. Lett. 2009; 11: 329
    • 7e Zeldin RM, Toste FD. Chem. Sci. 2011; 2: 1706
    • 7f Buzard DJ, Lopez L, Moody J, Kawasaki A, Schrader TO, Kasem M, Johnson B, Zhu X, Thoresen L, Kim SH, Gharbaoui T, Sengupta D, Calvano L, Krishnan A, Gao Y, Semple G, Edwards J, Barden J, Morgan M, Usmani K, Chen C, Sadeque A, Chen W, Christopher RJ, Thatte J, Fu L, Solomon M, Whelan K, Al-Shamma H, Gatlin J, Gaidarov I, Anthony T, Le M, Unett DJ, Stirn S, Blackburn A, Behan DP, Jones RM. ACS Med. Chem. Lett. 2014; 5: 1334
    • 7g Schrader TO, Johnson BR, Lopez L, Kasem M, Gharbaoui T, Sengupta D, Buzard D, Basmadjian C, Jones RM. Org. Lett. 2012; 14: 6306
    • 7h Tanaka M, Ubukata M, Matsuo T, Yasue K, Matsumoto K, Kajimoto Y, Ogo T, Inaba T. Org. Lett. 2007; 9: 3331
    • 7i Wilson RM, Thalji RK, Bergman RG, Ellman JA. Org. Lett. 2006; 8: 1745
    • 7j Liu JF, Jiang ZY, Wang RR, Zheng YT, Chen JJ, Zhang XM, Ma YB. Org. Lett. 2007; 9: 4127
    • 7k Sharma V, Kumar P, Pathak D. J. Heterocycl. Chem. 2010; 47: 491
    • 7l Chadha N, Silakari O. Eur. J. Med. Chem. 2017; 134: 159
    • 7m Norwood IV V. M, Huigens RW. III. ChemBioChem 2019; 20: 2273
    • 7n Mathada BS, Yernale NG, Basha JN. ChemistrySelect 2023; 8: e202204181
    • 7o Schmidt AW, Reddy KR, Knölker H.-J. Chem. Rev. 2012; 112: 3193
    • 7p Miaskiewicz S, Weibel J.-M, Pale P, Blanc A. RSC Adv. 2022; 12: 26966
    • 7q Zhang Z, Yi D, Zhang M, Wei J, Lu J, Yang L, Wang J, Hao N, Pan X, Zhang S, Wei S, Fu Q. ACS Catal. 2020; 10: 10149
    • 7r Somei M, Yamada F. Nat. Prod. Rep. 2004; 21: 278
    • 7s Cacchi S, Fabrizi G. Chem. Rev. 2005; 105: 2873
    • 7t Somei M, Yamada F. Nat. Prod. Rep. 2005; 22: 73
    • 7u Garg NK, Caspi DD, Stoltz BM. J. Am. Chem. Soc. 2005; 127: 5970
    • 7v Humphrey GR, Kuethe JT. Chem. Rev. 2006; 106: 2875
    • 7w Krajewski K, Zhang Y, Parrish D, Deschamps J, Roller PP, Pathak VK. Bioorg. Med. Chem. Lett. 2006; 16 3034
    • 7x Chen Z.-Z, Li S.-Q, Zhang Y.-J, Tang D.-Y, Meng J.-P, Lei J, Li H.-Y, Xu Z.-G. Org. Lett. 2018; 20: 7811
    • 8a Shelke YG, Hande PE, Gharpure SJ. Org. Biomol. Chem. 2021; 19: 7544
    • 8b Ríos M.-C, Portilla J. Chemistry 2022; 4: 940
    • 8c Lv Y, Meng J, Li C, Wang X, Ye Y, Sun K. Adv. Synth. Catal. 2021; 363: 5235
    • 8d Mustafa A, Siddiqui S, Umar Khan M, Qasem Ali AA, Siddiqui ZN. ChemistrySelect 2021; 6: 8611
    • 8e Li M.-M, Chen X, Deng Y, Lu J. RSC Adv. 2021; 11: 38060
  • 9 Zeng L, Guo X.-Q, Yang Z.-J, Gan Y, Chen L.-M, Kang T.-R. Tetrahedron Lett. 2019; 60: 150943
  • 10 Chen L.-M, Zhao J, Xia A.-J, Guo X.-Q, Gan Y, Zhou C, Yang Z.-J, Yang J, Kang T.-R. Org. Biomol. Chem. 2019; 17: 8561
  • 11 Yang J.-G, Xu L.-Z, Huang L, Gao J.-R, Liu M.-C, Pan F.-Y, Chen D.-B. Chin. Chem. Lett. 2016; 27: 340
    • 12a For a recent review on phosphazene base catalyzed reactions, see: Puleo TR, Sujansky SJ, Wright SE, Bandar JS. Chem. Eur. J. 2021; 27: 4216
    • 12b Shigeno M, Nakamura R, Hayashi K, Nozawa-Kumada K, Kondo Y. Org. Lett. 2019; 21: 6695
    • 12c Shigeno M, Hayashi K, Nozawa-Kumada K, Kondo Y. Chem. Eur. J. 2019; 25: 6077
    • 12d Shigeno M, Hayashi K, Nozawa-Kumada K, Kondo Y. Org. Lett. 2019; 21: 5505
    • 12e Shigeno M, Hayashi K, Nozawa-Kumada K, Kondo Y. Org. Lett. 2020; 22: 9107
    • 12f Shigeno M, Hayashi K, Korenaga T, Nozawa-Kumada K, Kondo Y. Org. Chem. Front. 2022; 9: 3656
    • 12g Shigeno M, Shishido Y, Hayashi K, Nozawa-Kumada K, Kondo Y. Eur. J. Org. Chem. 2021; 3932
  • 13 Wang X, Li Z, Cao S, Rao H. Adv. Synth. Catal. 2016; 358: 2059
  • 14 Walia PK, Sharma M, Kumar M, Bhalla V. RSC Adv. 2019; 9: 36198
  • 15 Experimental Procedure for the One-Pot Synthesis of Pyrazoloindolone 5a A round-bottomed flask (10 mL) fitted with a magnetic stir bar and nitrogen inlet was charged with cinnamaldehyDe (26.2 mg, 0.20 mmol) and MeOH (0.40 mL) at rt. Then TsNHNH2 (37.2 mg, 0.20 mmol) was added, and the mixture was stirred at rt for 3 h. During this time TLC analysis indicated complete conversion. Then, MeOH was evaporated, the residue was dissolved in dry DMSO (0.40 mL), and Cs2CO3 (81.5 mg, 0.25 mmol) was added under nitrogen atmosphere. The resulting mixture was placed in a pre-heated oil bath at 110 °C and stirred for 15 min. Then, 2-fluorobenzaldehyde 3a (24.8 mg, 0.20 mmol) and Cs2CO3 (146.6 mg, 0.45 mmol) were added, and the reaction mixture was stirred at 110 °C for 5 h. Then, the reaction mixture was purged with oxygen and heated at 130 °C under oxygen atmosphere (balloon) for 10 h. After cooling to rt, the reaction mixture was diluted with ethyl acetate (25 mL), extracted with brine (3 × 10 mL), dried over Na2SO4, and evaporated. The crude product was purified by silica gel column chromatography using 5% ethyl acetate in hexanes as eluent to obtain pyrazoloindolone 5a (32.1 mg, 65% yield) as a yellow-brown solid; mp 150–152 °C; Rf = 0.75 (0.5:9.5 ethyl acetate/hexane); purified using 2% ethyl acetate in hexanes as eluent. 1H NMR (500 MHz, CDCl3): δ = 7.76 (d, J = 6.5 Hz, 2 H), 7.53 (d, J = 6.5 Hz, 1 H), 7.45 (apt, J = 7.5 Hz, 1 H), 7.40–7.34 (m, 3 H), 7.29 (apt, J = 8.0 Hz, 1 H), 7.12 (apt, J = 8.0 Hz, 1 H), 6.86 (s, 1 H). 13C{1H} NMR (126 MHz, CDCl3): δ = 179.5, 157.9, 144.0, 139.7, 135.6, 132.0, 128.8, 128.7, 128.0, 126.3, 125.6, 124.9, 110.7, 103.3. HRMS (ESI-TOF): m/z calcd for C16H11N2O [M + H]+: 247.0871; found: 247.0842.